Migrahills Study Insights: What Researchers Observed in People with Recurring Headaches

By Herbal Hills Research Team | Medically reviewed by: Dr. Ajitkumar Mandlecha, BAMS, M.Phil (Musculoskeletal Disorder), Medical Director, Vishwanand Kendra, Pune

Ayurvedic treatment for migraine headaches is a common reason people consult Ayurvedic practitioners, particularly when headaches recur over months or years. Migrahills from Herbal Hills, a tablet including Ashwagandha and Shankhapushpi, was evaluated in a 90-day study measuring both headache intensity and day-to-day disability.

Quick answer: In a 90-day study published in the European Journal of Pharmaceutical and Medical Research (2025), adults with recurring migraine-type headaches took Migrahills tablets. Among the 35 who completed the study, mean MIDAS disability scores fell 63.24% and mean VAS headache scores fell from 5.15 to 3.70, both statistically significant (p<0.001).

Key takeaways

• Published: EJPMR, 2025, 12(8).
• 40 adults enrolled, 35 completed; 90 days.
• MIDAS (Migraine Disability Assessment) score: 3.58 → 1.28, 63.24% relief (p<0.001).
• VAS headache score: 5.15 ± 1.30 → 3.70 ± 1.10 (p<0.001).
• Formulation includes Ashwagandha (Withania somnifera) extract and Shankhapushpi (Convolvulus pluricaulis).

In this article

• What is Migrahills tablet?
• How significant is migraine as a health problem?
• What does Ayurvedic treatment for migraine headaches involve?
• How was the Migrahills study designed?
• What results did the study report?
• What is the MIDAS score, and why does it matter?
• Who was excluded from the study?
• Study at a glance
• Frequently asked questions

What is Migrahills tablet?

Migrahills is an Ayurvedic proprietary tablet formulated for people with recurring migraine-type headaches. Its herbs include Ashwagandha (Withania somnifera) root extract, traditionally used to relieve stress and support sleep, and Shankhapushpi (Convolvulus pluricaulis), traditionally used for nervous system wellness.

How significant is migraine as a health problem?

Migraine is a recurring headache, often on one side of the head, typically throbbing and frequently accompanied by nausea and light sensitivity. The Global Burden of Disease work cited in the study ranks migraine among the leading causes of disability worldwide, and it is a frequent reason people consult Ayurvedic practitioners.

What does Ayurvedic treatment for migraine headaches involve?

Ayurveda describes one-sided recurring headache under Ardhavabhedaka, linked mainly with Vata and Pitta imbalance. Ayurvedic management combines lifestyle and dietary measures with formulations that calm the nervous system, support sleep and address triggers such as stress, which is the approach Migrahills is designed around.

How was the Migrahills study designed?

Forty adults with daily or near-daily chronic headache with migraine-type exacerbations were enrolled; 35 completed the 90-day study. Participants included people with frequent analgesic use and willingness to follow an Ayurvedic regimen. Headache intensity was measured on the Visual Analogue Scale (VAS) and disability on the MIDAS questionnaire.

What results did the study report?

Mean MIDAS disability scores fell from 3.58 to 1.28, a 63.24% relief (p<0.001), and mean VAS headache scores fell from 5.15 to 3.70 (p<0.001). The authors concluded that Migrahills was safe and effective for migraine in the study group.

Migrahills
60 Tablets (Pack of 5)

View product →

Migrahills
900 Tablets (Value Pack)

View product →

What is the MIDAS score, and why does it matter?

The Migraine Disability Assessment (MIDAS) measures how many days headaches affect work, household tasks and social life over three months. A lower MIDAS score means less day-to-day disruption, which is often what matters most to patients and is a useful practical outcome for practitioners to track.

Who was excluded from the study?

People with headache linked to hypertension, head injury, raised intracranial pressure, major psychiatric or neurological disorders, or eye, ENT or dental disease were excluded. Practitioners should rule out these causes before considering Migrahills.

Study at a glance

About the research

Herbal Hills studies were conducted at Vishwanand Kendra, Centre for Integrative Medicine & Research, Pune, under Dr. Ajitkumar Mandlecha (Medical Director) and Dr. Gous Mujawar (Research Head), with Institutional Ethics Committee approval.

About Herbal Hills

Herbal Hills has spent over 25 years manufacturing Ayurvedic formulations in ISO and GMP certified facilities. Our ghee-based soft gel capsules are prepared with cow ghee from our own cow farm using the classical Siddha Ghruta method, and nine of our formulations have been evaluated in clinical studies, eight of them published in peer-reviewed journals. Doctors, clinics, distributors and medical stores can buy directly from the manufacturer in retail packs or value packs.

Registered Ayurvedic practitioners can request the full study summary and a free product sample for clinical evaluation. Share your name, clinic name and registration number through the enquiry form or WhatsApp button on this page.

Frequently asked questions

Disclaimer

This article is for educational purposes and is intended for healthcare professionals, clinic owners and trade partners. The results described were observed in the study participants named above; individual results may vary. Herbal Hills products are Ayurvedic proprietary medicines and should be used under the guidance of a qualified Ayurvedic practitioner. The studies referenced were sponsored by Herbal Hills and conducted by an independent research centre.

References

1. Mandlecha AK, Mujawar G. To evaluate safety and efficacy of tablet Migrahills in the subject of migraine. EJPMR. 2025;12(8).
2. Steiner TJ et al. Migraine: the seventh disabler. J Headache Pain. 2013;14:1.